Rense.com




7 Cancer Patients Given
Death Sentence When Exposed
to HCV In The Hospital

From Dr. Patricia Doyle, PhD
7-27-4


It appears that the hospital "two stepped" around this horrendous situation of infected cancer patients, hoping not to divulge the facts of human error which lead to the infection. They admit to 7 patients infected.
 
I am quite sure that the HCV rate is climbing in other countries as well due to noscominally transmitted HCV. In third world countries where reusing needles is common place, there must be a large number of people who are infected within the hospital setting. In Africa, the numbers of cases of people infected with Aids/HCV is alarming.
 
Contrary to the CDC's information, THERE IS NO CURE for Hepatitis C (HCV.) Interferon or combo of Interferon - Ribaviran is NOT a cure for HCV.
 
I estimate that over 3% of the US population has been exposed to HCV. Worldwide, well over 5% of the population is infected.
 
A diagnosis of Hepatitis C IS a DEATH SENTENCE and hospitals need to take every precaution to ensure HCV is not spreading.
 
Patricia Doyle
 
 
Spain - Hospital Transmission Of HCV In Cancer Unit
El Mundo
7-25-4
 
Translated from Spanish by Jorge Gonzales Mendoza
 
The Patient Protection Office, for Madrid Community, has opened an investigation in order to determine how 7 cancer patients contracted hepatitis C virus at the Hospital de Alcorcon Foundation. The hepatitis C outbreak has been denounced by various organizations, and, reported to the local Attorney's office .
 
Virgilo Castilla, spokesman for the hospital, who was its medical manager up until one month ago, and, who was present when the infections occurred in December 2003, confirmed that there were 7 infected patients, but, also, that there was no documentation of these infections until last February [2004], when laboratory tests were carried out. Following the test results, an internal investigation was opened at the Hospital, and, approximately at the beginning of March 2004, the occurrences were reported to the Health Council, which opened another "external investigation." The conclusions of the external investigation have not been made public.
 
Several hypotheses have been proposed in order to explain the outbreak, and it is anticipated that, in August 2004, a definitive report about the circumstances under which these infections occurred will be issued. Dr. Castilla said that the most feasible explanation was that the 7 patients infected were part of a group, comprising 18 cancer patients, who were together in the same Hospital Department. The definitive confirmation of this outbreak was the presence of a source patient, a person who has had hepatitis C infection for quite a long time, said Dr. Castilla.
 
The hospital, whose investigation is scheduled to be completed in August 2004, recognizes that there was human error involved, pointing out that the protocol for preventing infections, which states that the use of disposable materials, and careful device cleaning practices, "was not complied with at some time, and, according to the 1st hypothesis, certain materials could have contaminated other material." Dr. Castilla affirmed that there was no needle, or syringe, re-utilization. He gave assurances that the Alcorcon Hospital "reinforced" the protocol that mandates that used surgical materials be disposed of properly, and stated that, until now, the investigation has not been able to determine who was responsible for the infection.
 
Margarita Retuerto, an officer from the Patient Protection Office in Madrid, said that investigating this outbreak is a "high priority" for her office, and, she confirmed that an official investigation "has already been started" in order to determine the causes, and the circumstances, of this infection. Ms. Retuerto offered a "full guarantee" for patients and relatives that the conclusions of the investigation will be released "quickly and clearly," and that "all responsibilities will be established" on the basis of the aforementioned conclusions.
 
_____
 
Hepatitis C virus (HCV) infection, because it is primarily transmitted via blood, presents risks for both nosocomial transmission to patients, and, occupational spread to health care workers. Hemodialysis patients, in particular, are recognized as a group at increased risk of infection with HCV. Barril and Traver (Antiviral Res. 2003 Oct;60(2):129-34) reported recently that, in a Multicenter Spanish Study on HCV in Dialysis, strict adherence to universal infection control precautions proved to be adequate to prevent nosocomial transmission of HCV. Time was the most important factor (although interacting with the isolation measures) and was independent of initial HCV prevalence. A thorough analysis of this type may be necessary to identify the breakdown in infection control that led to the spread of hepatitis C virus among patients in the cancer treatment unit described above. - Mod.CP
 
 
 
Patricia A. Doyle, PhD Please visit my "Emerging Diseases" message board at: http://www.clickitnews.com/ubbthreads/postlist.php?
Cat=&Board=emergingdiseases
Zhan le Devlesa tai sastimasa
Go with God and in Good Health




Disclaimer






MainPage
http://www.rense.com


This Site Served by TheHostPros